Net loss of Panacea Biotec reported to Rs 15.88 crore in the quarter ended June 2024 as against net profit of Rs 10.98 crore during the previous quarter ended June 2023. Sales declined 10.43% to Rs 115.72 crore in the quarter ended June 2024 as against Rs 129.19 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 115.72 | 129.19 | -10 |
| OPM % | -12.09 | -7.98 | - |
| PBDT | -11.06 | -5.23 | -111 |
| PBT | -19.79 | -14.71 | -35 |
| NP | -15.88 | 10.98 | PL |